These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 8599089

  • 21. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ, McGonigle S, Pearce EJ.
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [Abstract] [Full Text] [Related]

  • 22. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
    Rotzer D, Roth M, Lutz M, Lindemann D, Sebald W, Knaus P.
    EMBO J; 2001 Feb 01; 20(3):480-90. PubMed ID: 11157754
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
    Doré JJ, Edens M, Garamszegi N, Leof EB.
    J Biol Chem; 1998 Nov 27; 273(48):31770-7. PubMed ID: 9822641
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
    Anders RA, Doré JJ, Arline SL, Garamszegi N, Leof EB.
    J Biol Chem; 1998 Sep 04; 273(36):23118-25. PubMed ID: 9722540
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M.
    J Biol Chem; 1993 Jun 15; 268(17):12719-23. PubMed ID: 8389764
    [Abstract] [Full Text] [Related]

  • 30. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU, de Gorter DJ, Aartsma-Rus A, van Ommen GJ, ten Dijke P, 't Hoen PA, Hoogaars WM.
    FASEB J; 2012 Apr 15; 26(4):1462-72. PubMed ID: 22202673
    [Abstract] [Full Text] [Related]

  • 31. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ, Vale WW.
    Mol Cell Biol; 1997 Mar 15; 17(3):1682-91. PubMed ID: 9032295
    [Abstract] [Full Text] [Related]

  • 32. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
    Barbara NP, Wrana JL, Letarte M.
    J Biol Chem; 1999 Jan 08; 274(2):584-94. PubMed ID: 9872992
    [Abstract] [Full Text] [Related]

  • 33. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
    Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C.
    Nature; 1999 Sep 30; 401(6752):480-5. PubMed ID: 10519551
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N, Mottershead DG, Mazerbourg S, Myllymaa S, Duprat S, Gilchrist RB, Groome NP, Hsueh AJ, Ritvos O.
    J Clin Endocrinol Metab; 2005 Jan 30; 90(1):271-8. PubMed ID: 15483083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.